Intradermal insulin delivery: A promising future for diabetes management
2014 (English)In: Journal of Diabetes Science and Technology, ISSN 1932-2968, Vol. 8, no 3, 453-457 p.Article in journal (Refereed) Published
The incidence of insulinopenic diabetes mellitus is constantly increasing, and in addition, approximately a third of all hyperinsulinemic diabetic patients develop insulinopenia. Optimal glycemic control is essential to minimize the risk for diabetes-induced complications, but the majority of diabetic patients fail to achieve proper long-term glucose levels even in clinical trials, and even more so in clinical practice. Compliance with a treatment regimen is likely to be higher if the procedure is simple, painless, and discreet. Thus, insulin has been suggested for nasal, gastrointestinal, and inhalation therapy, but so far with considerable downsides in effect, side effects, or patient acceptance. The stratum corneum is the main barrier preventing convenient drug administration without the drawbacks of subcutaneous injections. Recently, devices with miniaturized needles have been developed that combine the simplicity and discretion of patch-based treatments, but with the potential of peptide and protein administration. As this review describes, initial comparisons with subcutaneous administration now suggest microneedle patches for active insulin delivery are efficient in maintaining glycemic control. Hollow microneedle technology could also prove to be efficient in systemic as well as local delivery of other macromolecular drugs, such as vaccines.
Place, publisher, year, edition, pages
2014. Vol. 8, no 3, 453-457 p.
Diabetes, Hollow, Insulin, Intradermal, Microneedles, Transdermal, glucose, peptide, protein, blood glucose monitoring, conference paper, diabetes mellitus, diabetic patient, drug delivery device, drug delivery system, glucose blood level, glycemic control, human, hypoinsulinemia, insulin treatment, long term care, macromolecule, microelectromechanical system, microneedle, microtechnology, patient compliance, risk reduction
Microbiology in the medical area
IdentifiersURN: urn:nbn:se:kth:diva-167569DOI: 10.1177/1932296814530060ScopusID: 2-s2.0-84900792717OAI: oai:DiVA.org:kth-167569DiVA: diva2:816078
QC 201506022015-06-022015-05-222015-06-02Bibliographically approved